Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

NCT07436078 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2026-02-27

No results posted yet for this study

Summary

The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investigators will:

* adapt and refine a culturally relevant online educational genetic counseling program for at-risk African Americans
* Test the effects of the educational program
* collaborate with community leaders and clinical genetic professionals to translate study findings, develop a road map for dissemination to the community, and identify barriers to prepare for future trials.

Participants from Detroit Research on Cancer Survivor group will be offered enrollment. Once consent is obtained, questionnaires will be completed before an online genetic counselling intervention immediately after, and at 3 months

Conditions

Interventions

BEHAVIORAL

Culturally adapted Online Genetic Counseling and Testing Information

Testing the effects of the educational intervention designed to increase the uptake of genetic counseling testing among at-risk African American survivors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Barbara Ann Karmanos Cancer Institute

    lead OTHER

Principal Investigators

  • Felicity WK Harper, Ph.D · Barbara Ann Karmanos Cancer Institute

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2029-07-31
Completion
2029-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07436078 on ClinicalTrials.gov